Mettler-Toledo International, Inc. Common Stock (MTD)
Healthcare › Laboratory Analytical Instruments
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- Trading 1,273% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- Strong ROE of 448.6% with 19.6% net margin
Mettler-Toledo International, Inc. Common Stock (MTD) is a Healthcare company operating in Laboratory Analytical Instruments, listed on the NYSE , with a market capitalisation of $22.3 billion . Key value metrics: P/E ratio 29.6, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Mettler-Toledo International, Inc. Common Stock — Fundamental Analysis Summary
Mettler-Toledo International, Inc. Common Stock (MTD) is currently trading 1,273% above its Graham Number of $80.34, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 29.6x.
On financial health, MTD shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 448.6% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 9.22.
StockPik's composite Value Score for MTD is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MTD shows revenue growing at 4% year-over-year, with earnings growing at 1%.